Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CITIC Pharmaceutical Co., Ltd. was a leading pharmaceutical distribution and healthcare services provider in China, primarily serving the Beijing and Northern China markets. As one of the top three distributors in Beijing, the company specialized in the wholesale, logistics, and supply chain management of pharmaceuticals, medical devices, and healthcare information technology. In 2011, the company was acquired by Shanghai Pharmaceuticals Holding Co., Ltd. (Shanghai Pharma) for approximately 4 billion RMB, a landmark deal that significantly expanded Shanghai Pharma's footprint in Northern China. Following the acquisition, the entity was integrated into Shanghai Pharma's northern platform and renamed Shanghai Pharma Keyuan Xinhai Pharmaceutical Co., Ltd. (SPH Keyuan). Although the original entity is no longer independent, the CITIC Group continues to operate in the healthcare sector through its subsidiary, CITIC Medical & Health Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CITIC Pharmaceutical.